Therapeutic Advances in Urology (Jun 2023)

Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay

  • Umberto Carbonara,
  • Daniele Amparore,
  • Leonardo D. Borregales,
  • Anna Caliò,
  • Chiara Ciccarese,
  • Pietro Diana,
  • Selcuk Erdem,
  • Laura Marandino,
  • Michele Marchioni,
  • Constantijn H.J. Muselaers,
  • Carlotta Palumbo,
  • Nicola Pavan,
  • Angela Pecoraro,
  • Eduard Roussel,
  • Hannah Warren,
  • Zhen-Jie Wu,
  • Riccardo Campi,
  • Riccardo Bertolo

DOI
https://doi.org/10.1177/17562872231172834
Journal volume & issue
Vol. 15

Abstract

Read online

Single-port (SP) robotic surgery is a novel technology and is at the beginning of its adoption curve in urology. The goal of this narrative review is to provide an overview of SP-robotic partial nephrectomy (PN) 4 years after the introduction of the da Vinci SP dedicated platform, focusing on perioperative outcomes, length of stay, and surgical technique. A nonsystematic review of the literature was conducted. The research included the most updated articles that referred to SP robotic PN. Since its commercial release in 2018, several institutions have reproduced robotic PN by using the SP platform, both via a transperitoneal and a retroperitoneal approach. The published SP-robotic PN series are generally based on preliminary experiences by surgeons who had previous experience with conventional multi-arms robotic platforms. The reported outcomes are encouraging. Overall, three studies reported that SP-robotic PN cases had nonsignificantly different operative time, estimated blood loss, overall complications rate, and length of stay compared to the conventional ‘multi-arms’ robotic PN. However, in all these series, renal masses treated by SP had overall lower complexity. Moreover, two studies underlined decreased postoperative pain as a major pro of adopting the SP system. This should reduce/avoid the need for opioids after surgery. No study compared SP-robotic versus multi-arms robotic PN in cost-effectiveness. Published experience with SP-robotic PN has reported the feasibility and safety of the approach. Preliminary results are encouraging and at least noninferior with respect to those from the multi-arms series. Prospective comparative studies with long-term oncologic and functional results are awaited to draw more definitive conclusions and better establish the more appropriate indications of SP robotics in the field of PN.